Experiments to generate REC-1 cells with a silenced alternative NFκB pathway in order to strengthen the functional role of this pathway in drug resistance were unsuccessful and further studies are needed to decipher the substantial role of the alternative NFκB pathway in MCL. The gene discussed is NFKB1; the disease is mantle cell lymphoma.